TrialPanorama/TrialPanorama-database huggingface dataset:
Study NCT05834751 — Predictive Biomarker (PRD); Safety Biomarker (SAF): White blood cell
Study NCT06626633 — Predictive Biomarker (PRD): STING1 mRNA
Genes: STING1; ERIS; MITA; STING; TMEM173
Study NCT06731803 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04728828 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06742723 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05332756 — Predictive Biomarker (PRD): RNF213 mRNA
Genes: RNF213; ALO17; C17orf27; KIAA1554; KIAA1618; MYSTR
Study NCT06289517 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05501886 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05501886 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05501886 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT05501886 — Predictive Biomarker (PRD): PIK3CA mRNA
Genes: PIK3CA
Study NCT05885412 — Predictive Biomarker (PRD): PKP2 mRNA
Genes: PKP2
Study NCT05795504 — Surrogate Endpoint (SUR): Serum calcium
Study NCT04773899 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT04773899 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05411276 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06254807 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05818813 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05245006 — Predictive Biomarker (PRD): CD46 mRNA
Genes: CD46; MCP; MIC10
Study NCT05512104 — Predictive Biomarker (PRD): CD200 mRNA
Genes: CD200; MOX1; MOX2; My033
Study NCT04692155 — Predictive Biomarker (PRD): CCND1
Genes: U21B31
Study NCT06234423 — Predictive Biomarker (PRD): CDH6 mRNA
Genes: CDH6
Study NCT05349318 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT06323538 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05216562 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT05116917 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05378204 — Predictive Biomarker (PRD): POLQ mRNA
Genes: POLQ; POLH
Study NCT06251180 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT06258681 — Surrogate Endpoint (SUR): Forced vital capacity
Study NCT04965935 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT04965935 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04486118 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT05077449 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05077449 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05846282 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05078021 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06429371 — Pharmacodynamic Biomarker (PDY): Heat pain threshold
Study NCT04790695 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study NCT04790695 — Predictive Biomarker (PRD): ERBB3 mRNA
Genes: ERBB3; HER3
Study NCT04790695 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05676749 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05398094 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05180422 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT05282199 — Predictive Biomarker (PRD): MIP mRNA
Genes: MIP; AQP0
Study NCT06078748 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05316454 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06627257 — Predictive Biomarker (PRD): LEP mRNA
Genes: LEP; OB; OBS
Study NCT06112379 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06112379 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06742593 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT04777084 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04777084 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT04777084 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT05461768 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05973513 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05224531 — Predictive Biomarker (PRD): CLSTN1 mRNA
Genes: CLSTN1; CS1; KIAA0911
Study NCT05224531 — Predictive Biomarker (PRD): PAH mRNA
Genes: PAH
Study NCT05482568 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04938635 — Predictive Biomarker (PRD): VIT mRNA
Genes: VIT; UNQ647/PRO1277
Study NCT05167526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05932563 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT06201390 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05502835 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06144996 — Predictive Biomarker (PRD): NTM mRNA
Genes: NTM; IGLON2; NT; UNQ297/PRO337
Study NCT05138250 — Predictive Biomarker (PRD): Interleukin 5
Genes: IL5
Study NCT05260957 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT06016738 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06016738 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT06423014 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04606550 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05900648 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT05931458 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05444647 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04825847 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06426225 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06561607 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06561607 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT04964115 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05592574 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05592574 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Interleukin 17
Genes: IL17A; CTLA8; IL17
Study NCT05793398 — Predictive Biomarker (PRD): CS mRNA
Genes: CS
Study NCT06320067 — Predictive Biomarker (PRD): ARSI mRNA
Genes: ARSI
Study NCT06320067 — Predictive Biomarker (PRD): Glutamate carboxypeptidase II
Genes: FOLH1; FOLH; NAALAD1; PSM; PSMA; GIG27
Study NCT04965688 — Predictive Biomarker (PRD): CDK4 mRNA
Genes: CDK4
Study NCT04965688 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT05293366 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT06219031 — Predictive Biomarker (PRD): CD55 mRNA
Genes: CD55; CR; DAF
Study NCT06219031 — Predictive Biomarker (PRD): TMEM37 mRNA
Genes: TMEM37; PR
Study NCT05963646 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT06603597 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT04222023 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05347459 — Predictive Biomarker (PRD): SLC5A2 mRNA
Genes: SLC5A2; SGLT2
Study NCT05347459 — Pharmacodynamic Biomarker (PDY): Dipeptidyl peptidase 4
Genes: DPP4; ADCP2; CD26
Study NCT05976815 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06368154 — Surrogate Endpoint (SUR): Bone mineral density
Study NCT05463601 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05463601 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05463601 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT04640129 — Monitoring Biomarker (MOI): HBV DNA
Study NCT05731687 — Predictive Biomarker (PRD); Safety Biomarker (SAF): DES mRNA
Genes: DES
Study NCT05813418 — Safety Biomarker (SAF): PDCD1
Genes: CD279; PD1; hSLE1; PD-1
Study NCT05813418 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT00703235 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT00703235 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05157217 — Safety Biomarker (SAF): ACE
Genes: ACE1; CD143
Study NCT05157217 — Predictive Biomarker (PRD): ACE2 mRNA
Genes: ACE2; UNQ868/PRO1885
Study NCT05157217 — Predictive Biomarker (PRD): TMPRSS2 mRNA
Genes: TMPRSS2; PRSS10
Study NCT05157217 — Pharmacodynamic Biomarker (PDY): Angiotensin-converting enzyme
Genes: ACE; DCP; DCP1
Study NCT06123689 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT05508373 — Predictive Biomarker (PRD): ENTPD1 mRNA
Genes: ENTPD1; CD39
Study NCT05648799 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05701384 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06043388 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05828511 — Predictive Biomarker (PRD): TNFRSF17 mRNA
Genes: TNFRSF17; BCM; BCMA
Study NCT05409651 — Safety Biomarker (SAF): Reactive oxygen species
Study NCT06194877 — Predictive Biomarker (PRD): RAF1 mRNA
Genes: RAF1; RAF
Study NCT06194877 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06194877 — Predictive Biomarker (PRD): NRAS mRNA
Genes: NRAS; HRAS1
Study NCT05189106 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): Interferon gamma
Genes: IFNG
Study NCT05442034 — Predictive Biomarker (PRD): EMD mRNA
Genes: EMD; EDMD; STA
Study NCT04823091 — Predictive Biomarker (PRD): CD7 mRNA
Genes: CD7
Study NCT05469360 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY): Microtubule-associated protein tau
Genes: MAPT; MAPTL; MTBT1; TAU
Study NCT04282174 — Predictive Biomarker (PRD): CD34 mRNA
Genes: CD34
Study NCT04282174 — Predictive Biomarker (PRD): CSF3 mRNA
Genes: CSF3; C17orf33; GCSF
Study NCT04403347 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05521360 — Predictive Biomarker (PRD): AMT mRNA
Genes: AMT; GCST
Study NCT05877274 — Predictive Biomarker (PRD): SCN9A mRNA
Genes: SCN9A; NENA
Study NCT05439707 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05216406 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05714670 — Predictive Biomarker (PRD): NLRP3 mRNA
Genes: NLRP3; C1orf7; CIAS1; NALP3; PYPAF1
Study NCT05714670 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05714670 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT06614647 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT06615388 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05710354 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Serum albumin
Genes: ALB; GIG20; GIG42; PRO0903; PRO1708; PRO2044; PRO2619; PRO2675; UNQ696/PRO1341
Study NCT05451264 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06422520 — Predictive Biomarker (PRD): CD276 mRNA
Genes: CD276; B7H3; PSEC0249; UNQ309/PRO352
Study NCT06696365 — Predictive Biomarker (PRD): F3 mRNA
Genes: F3
Study NCT06697626 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Monitoring Biomarker (MOI): Vitamin B12
Study NCT06697080 — Predictive Biomarker (PRD): AGA mRNA
Genes: AGA
Study NCT05010694 — Predictive Biomarker (PRD): KRAS mRNA
Genes: KRAS; KRAS2; RASK2
Study NCT06336044 — Safety Biomarker (SAF): Hyaluronic acid
Study NCT06626867 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05272813 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase BTK
Genes: BTK; AGMX1; ATK; BPK
Study NCT04626245 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06140082 — Safety Biomarker (SAF): Glutathione S-transferase P
Genes: GSTP1; FAEES3; GST3
Study NCT06437925 — Monitoring Biomarker (MOI): Matrix metalloproteinase 8
Genes: MMP8; CLG1
Study NCT06737354 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06742502 — Predictive Biomarker (PRD): DDIT3 mRNA
Genes: DDIT3; CHOP; CHOP10; GADD153
Study NCT06084416 — Predictive Biomarker (PRD): KIF18A mRNA
Genes: KIF18A; OK/SW-cl.108
Study NCT06145308 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06145308 — Predictive Biomarker (PRD): AR mRNA
Genes: AR; DHTR; NR3C4
Study NCT06237322 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04974866 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT04974866 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04332198 — Predictive Biomarker (PRD): POMC
Genes: MSH; POC; CLIP; ACTH; NPP; LPH
Study NCT04332198 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04332198 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT04332198 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Interleukin 8
Genes: CXCL8; IL8
Study NCT04332198 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 10
Genes: IL10
Study NCT04332198 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05266001 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06196554 — Predictive Biomarker (PRD): CDX2 mRNA
Genes: CDX2; CDX3
Study NCT05801822 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT06557954 — Predictive Biomarker (PRD): PAX1 mRNA
Genes: PAX1; HUP48
Study NCT06557954 — Predictive Biomarker (PRD): JAM3 mRNA
Genes: JAM3; UNQ859/PRO1868
Study NCT04231643 — Pharmacodynamic Biomarker (PDY): Homovanillic acid
Study NCT05582967 — Safety Biomarker (SAF); Monitoring Biomarker (MOI): D-dimer
Study NCT04180969 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT04180969 — Surrogate Endpoint (SUR): Blood pressure
Study NCT03941782 — Predictive Biomarker (PRD); Safety Biomarker (SAF): PIK3CA
Genes: PI3K
Study NCT04879537 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06391450 — Predictive Biomarker (PRD): PRKD1 mRNA
Genes: PRKD1; PKD; PKD1; PRKCM
Study NCT06391450 — Surrogate Endpoint (SUR): Total kidney volume
Study NCT06408168 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06408168 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT04410653 — Predictive Biomarker (PRD): NRG1 mRNA
Genes: NRG1; GGF; HGL; HRGA; NDF; SMDF
Study NCT04410653 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT06058845 — Predictive Biomarker (PRD): TG mRNA
Genes: TG
Study NCT06518512 — Predictive Biomarker (PRD): AMD1 mRNA
Genes: AMD1; AMD
Study NCT04998526 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06201234 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT06201234 — Predictive Biomarker (PRD): Estrogen receptor
Genes: ESR1; ESR; NR3A1
Study NCT06201234 — Predictive Biomarker (PRD): Hormone receptor
Study NCT06154408 — Predictive Biomarker (PRD): PPARG mRNA
Genes: PPARG; NR1C3
Study NCT06154408 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05154890 — Predictive Biomarker (PRD): CBS mRNA
Genes: CBS
Study NCT06289296 — Predictive Biomarker (PRD): LCT mRNA
Genes: LCT; LPH
Study NCT06439238 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06468254 — Monitoring Biomarker (MOI): Ovarian carcinoma antigen CA125
Genes: MUC16; CA125
Study NCT05257564 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05465902 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05465902 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT04808362 — Predictive Biomarker (PRD): MYC mRNA
Genes: MYC; BHLHE39
Study NCT05725499 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05705570 — Predictive Biomarker (PRD): B-lymphocyte surface antigen B4
Genes: CD19
Study NCT05364177 — Predictive Biomarker (PRD): CXCR4 mRNA
Genes: CXCR4
Study NCT06345235 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Growth/differentiation factor 15
Genes: GDF15; MIC1; PDF; PLAB; PTGFB
Study NCT06345235 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Metalloproteinase inhibitor 1
Genes: TIMP1; CLGI; TIMP
Study NCT06345235 — Predictive Biomarker (PRD): TTR mRNA
Genes: TTR; PALB
Study NCT06345235 — Pharmacodynamic Biomarker (PDY): Matrix metalloproteinase 9
Genes: MMP9; CLG4B
Study NCT05582343 — Predictive Biomarker (PRD): COPE mRNA
Genes: COPE
Study NCT06014424 — Predictive Biomarker (PRD): PICALM mRNA
Genes: PICALM; CALM
Study NCT04985435 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT04704960 — Monitoring Biomarker (MOI): Circulating tumor DNA
Study NCT00113958 — Predictive Biomarker (PRD): Intact parathyroid hormone
Study NCT00113958 — Surrogate Endpoint (SUR): Serum calcium
Study NCT05562869 — Safety Biomarker (SAF): Cytotoxic T-lymphocyte protein 4
Genes: CTLA4; CD152
Study NCT05562869 — Predictive Biomarker (PRD): CD28 mRNA
Genes: CD28
Study NCT05605379 — Predictive Biomarker (PRD): BCR mRNA
Genes: BCR; BCR1; D22S11
Study NCT05605379 — Pharmacodynamic Biomarker (PDY): Tyrosine-protein kinase ABL1
Genes: ABL1; ABL; JTK7
Study NCT06123195 — Surrogate Endpoint (SUR): Serum creatinine
Study NCT05927961 — Predictive Biomarker (PRD): KCNJ5 mRNA
Genes: KCNJ5; GIRK4
Study NCT05927961 — Predictive Biomarker (PRD): CACNA1D mRNA
Genes: CACNA1D; CACH3; CACN4; CACNL1A2; CCHL1A2
Study NCT05927961 — Predictive Biomarker (PRD): CLCN2 mRNA
Genes: CLCN2
Study NCT05685641 — Predictive Biomarker (PRD): CD4 mRNA
Genes: CD4
Study NCT06283082 — Predictive Biomarker (PRD): AGXT mRNA
Genes: AGXT; AGT1; SPAT
Study NCT06283082 — Surrogate Endpoint (SUR): Urinary oxalate
Study NCT05170542 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT06281782 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Vascular endothelial growth factor A
Genes: VEGFA; VEGF
Study NCT06281782 — Predictive Biomarker (PRD); Safety Biomarker (SAF): Hepatocyte growth factor
Genes: HGF; HPTA
Study NCT06281782 — Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY): Vascular endothelial growth factor
Study NCT05463211 — Predictive Biomarker (PRD): CP mRNA
Genes: CP
Study NCT05284539 — Predictive Biomarker (PRD); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Epidermal growth factor receptor
Genes: EGFR; ERBB; ERBB1; HER1
Study NCT05284539 — Predictive Biomarker (PRD): ALK tyrosine kinase receptor
Genes: ALK
Study NCT05284539 — Predictive Biomarker (PRD): ROS1 mRNA
Genes: ROS1; MCF3; ROS
Study NCT00476814 — Pharmacodynamic Biomarker (PDY): Nasal potential difference
Study NCT05414851 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05944601 — Predictive Biomarker (PRD): Apolipoprotein E
Genes: APOE
Study NCT06448052 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05299463 — Surrogate Endpoint (SUR): Blood pressure
Study NCT06277128 — Surrogate Endpoint (SUR): Serum potassium
Study NCT04382963 — Surrogate Endpoint (SUR): Blood pressure
Study NCT04866303 — Predictive Biomarker (PRD): SARS1 mRNA
Genes: SARS1; SARS; SERS
Study NCT05948163 — Monitoring Biomarker (MOI): Adenosine deaminase
Genes: ADA; ADA1
Study NCT06318598 — Predictive Biomarker (PRD): IGFALS mRNA
Genes: IGFALS; ALS
Study NCT06318598 — Safety Biomarker (SAF): Granulocyte-macrophage colony-stimulating factor
Genes: CSF2; GMCSF
Study NCT06188663 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05862805 — Predictive Biomarker (PRD): TFPI mRNA
Genes: TFPI; LACI; TFPI1
Study NCT05862805 — Safety Biomarker (SAF): Plasminogen activator inhibitor
Genes: SERPINE1; PAI1; PLANH1
Study NCT06211556 — Predictive Biomarker (PRD): FGF21 mRNA
Genes: FGF21; UNQ3115/PRO10196
Study NCT06404463 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05644184 — Surrogate Endpoint (SUR): Neutralizing antibody
Study NCT05252988 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05252988 — Predictive Biomarker (PRD): HR mRNA
Genes: HR
Study NCT05252988 — Predictive Biomarker (PRD): Hormone receptor
Study NCT04739358 — Predictive Biomarker (PRD): Proto-oncogene c-Met
Genes: MET
Study NCT06351332 — Predictive Biomarker (PRD): WEE1 mRNA
Genes: WEE1
Study NCT06563193 — Predictive Biomarker (PRD): Nerve growth factor
Genes: NGF; NGFB
Study NCT06563193 — Predictive Biomarker (PRD); Monitoring Biomarker (MOI): BDNF mRNA
Genes: BDNF
Study NCT06563193 — Safety Biomarker (SAF): BDNF
Study NCT04828616 — Predictive Biomarker (PRD): Erbb2 tyrosine kinase receptor
Genes: ERBB2; HER2; MLN19; NEU; NGL
Study NCT05906251 — Predictive Biomarker (PRD): DYSF mRNA
Genes: DYSF; FER1L1
Study NCT06555939 — Predictive Biomarker (PRD): SCD mRNA
Genes: SCD; FADS5; SCD1; SCDOS
Study NCT05982860 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT05982860 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT05982860 — Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Neurofilament light polypeptide
Genes: NEFL; NF68; NFL
Study NCT05982860 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Interleukin 6
Genes: IL6; IFNB2
Study NCT06033417 — Surrogate Endpoint (SUR): Blood pressure
Study NCT05323981 — Monitoring Biomarker (MOI): Epidermal growth factor
Genes: EGF
Study NCT06087068 — Safety Biomarker (SAF): Thyroid stimulating hormone
Study NCT05250323 — Pharmacodynamic Biomarker (PDY): Huntingtin
Genes: HTT; HD; IT15
Study NCT05462548 — Predictive Biomarker (PRD): Liver iron
Study NCT05985863 — Predictive Biomarker (PRD): MSC mRNA
Genes: MSC; ABF1; BHLHA22
Study NCT06180382 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): Tumor necrosis factor
Genes: TNF; TNFA; TNFSF2
Study NCT06180382 — Predictive Biomarker (PRD); Safety Biomarker (SAF); Pharmacodynamic Biomarker (PDY); Monitoring Biomarker (MOI): C-reactive protein
Genes: CRP; PTX1
Study NCT06433232 — Predictive Biomarker (PRD): TNFRSF11A mRNA
Genes: TNFRSF11A; RANK